spirCare
Lung Capacity Measuring Device
Company Overview
Snapshot
Founded in February 2016, spirCare operated with 1–10 employees. The company secured funding in one round from Sanara Ventures. In March 2017, spirCare received a Seed investment from Sanara Ventures.
Business overview
spirCare developed a mobile, handheld device designed to measure the functional residual capacity of the lungs and airway resistance without requiring patient cooperation or causing breathing interruptions. This technology aimed to replace traditional lung volume measurement devices like body plethysmography, enabling remote monitoring for patients with chronic obstructive pulmonary disease in various settings, including home, clinics, and bedside, even for unconscious patients. The device could connect to spirometers, ventilators, or other tube-shaped devices attached to a patient's mouth, operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Devices.
Log in to access full profile ›Company Intelligence Q&A
- What is spirCare's primary product?
- spirCare developed a small, mobile, handheld device for measuring the functional residual capacity of the lungs and airway resistance, designed to replace traditional lung volume measurement devices.
- When was spirCare founded?
- spirCare was founded in February 2016.
- What is the operational status of spirCare?
- spirCare is non-active and ceased operations in December 2019.
- Which investor participated in spirCare's funding round?
- In March 2017, spirCare received a Seed investment from Sanara Ventures, which was the sole investor in that round.
- What problem did spirCare's technology aim to solve?
- spirCare's device aimed to enable monitoring of patients with chronic obstructive pulmonary disease at home, in clinics, and at the bedside, even if the patient is unconscious, by providing a portable alternative to traditional lung volume measurement tools.